These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32202017)

  • 61. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers.
    Planchamp C; Gex-Fabry M; Becker CD; Pastor CM
    Invest Radiol; 2007 Jul; 42(7):513-21. PubMed ID: 17568274
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
    Piscaglia F; Iavarone M; Galassi M; Vavassori S; Renzulli M; Forzenigo LV; Granito A; Salvatore V; Sangiovanni A; Golfieri R; Colombo M; Bolondi L
    Dig Dis; 2015 Oct; 33(6):735-44. PubMed ID: 26488875
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
    Reimer P; Rummeny EJ; Daldrup HE; Hesse T; Balzer T; Tombach B; Peters PE
    Eur Radiol; 1997; 7(2):275-80. PubMed ID: 9038130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.
    Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH
    Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
    J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of models and contrast agents for improved signal and signal linearity in dynamic contrast-enhanced pulmonary magnetic resonance imaging.
    Bell LC; Wang K; Munoz Del Rio A; Grist TM; Fain SB; Nagle SK
    Invest Radiol; 2015 Mar; 50(3):174-8. PubMed ID: 25501016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
    Reimer P; Schneider G; Schima W
    Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atypical Enhancement of Gd-BOPTA on the Hepatobiliary Phase in Hepatic Metastasis from Carcinoid Tumor - Case Report.
    Pozowski P; Misiak P; Szymańska K; Mazur R; Sierpowska M; Silicki J; Celmer M; Łasecki M; Pawluś A; Zaleska-Dorobisz U
    Am J Case Rep; 2020 Sep; 21():e924280. PubMed ID: 32883944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
    Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
    Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
    Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
    J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI.
    Lee MS; Lee JY; Kim SH; Park HS; Kim SH; Lee JM; Han JK; Choi BI
    J Magn Reson Imaging; 2011 Jan; 33(1):149-59. PubMed ID: 21182133
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
    Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
    Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
    Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
    J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Respiratory motion artefacts in Gd-EOB-DTPA (Primovist/Eovist) and Gd-DOTA (Dotarem)-enhanced dynamic phase liver MRI after intensified and standard pre-scan patient preparation: A bi-institutional analysis.
    Wybranski C; Siedek F; Damm R; Gazis A; Wenzel O; Haneder S; Persigehl T; Steinhauser S; Pech M; Fischbach F; Fischbach K
    PLoS One; 2020; 15(3):e0230024. PubMed ID: 32196535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
    Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
    Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
    Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
    Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.